Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This review discusses the controversial cardiovascular safety and efficacy of subcutaneous testosterone therapy in postmenopausal women, noting that its long-term use appears safe, but CV risk assessments remain disputed.

In this study, a 6-month randomized controlled trial with postmenopausal women reported that supplementing with soy protein isolate with isoflavones led to significant improvements in skin hydration and reduced wrinkles and facial pigment intensity, but did not affect sebum production.

This case report suggests that ovarian steroid cell tumors should be considered in postmenopausal women with hirsutism and elevated testosterone, with surgery being effective in resolving symptoms and preventing recurrence.

This article reviews potential causes of frontal fibrosing alopecia but does not provide new clinical findings.

This review discusses the potential role of hormone therapies in preventing or reversing age-related aesthetic changes in postmenopausal women and reports no clinical results; it suggests these treatments may be safely and effectively used by dermatologists.

Hair loss in women can be caused by genetics, menopause, certain health conditions, and emotional stress, and it often results in thinner hair and a changing hairline.

This review discusses the impact of menopause on oral health and emphasizes the adverse effects of falling oestrogen levels on oral tissues, calling for more research into treatments like hormone replacement therapy.

This study found that asthma and high testosterone levels were linked to more severe COVID-19 and higher mortality, while progesterone appeared to offer protective effects in pre-menopausal women.

This review reported that 5-alpha-reductase inhibitors were effective in stabilizing disease progression or reducing the rate of progression in some cases of frontal fibrosing alopecia, though evidence on safety remains limited.

This study identified that trichoscopy can effectively diagnose frontal fibrosing alopecia by highlighting specific scalp abnormalities in postmenopausal women.

This study found that vitamin D, vitamin B12, and iron deficiencies, along with thyroid dysfunction, may be associated with telogen effluvium.

This meta-analysis found that the prevalence of PCOS among Iranian women varies by diagnostic criteria, with notable rates of associated complications like hirsutism, acne, and menstrual disorders.

In this case study, a 69-year-old woman with signs of virilization and high testosterone levels was found to have an ovarian steroid cell tumor, highlighting the importance of systematically investigating such symptoms in postmenopausal women to determine the underlying etiology and prevent poor prognosis.

This article discusses the challenges in diagnosing female androgen insufficiency syndrome due to unreliable testosterone measurement methods but notes symptom improvement with testosterone therapy, emphasizing the need for women-specific formulations and safety guidelines.

This guideline provides evidence-based recommendations for prescribing testosterone therapy to women with hypoactive sexual desire disorder, noting a moderate therapeutic benefit but highlighting limited data and regulatory challenges.

This review highlights significant health risks associated with anabolic-androgenic steroid use in women and reports no new research results, emphasizing the need for further understanding of their effects on female physiology.

This narrative review synthesized current research on hormonal therapies in cosmetic dermatology, finding they offer promising, evidence-based applications for conditions like aging skin, acne, and melasma, but noting that safety and personalized treatment approaches are essential for responsible clinical use.

In this study, zinc deficiency, iron depletion, and thyroid abnormalities were commonly observed in female pattern hair loss patients, suggesting the benefit of testing for these conditions.

This study reported that frontal fibrosing alopecia predominantly affects postmenopausal women and identified potential risk factors like frequent β-blocker use and sunscreen application, indicating the need for further research.

This article discusses the common dermatological issues in adolescence linked to hormone fluctuations, such as acne and excessive sweating, and reports no new clinical results.

Women experience various skin issues at different life stages, requiring careful treatment and awareness.

This review examines hair and skin disorders in post-menopausal women and notes a lack of evidence supporting specific treatments for this population.

SA linked to mitochondrial issues and oxidative stress, while AGA involves disrupted hair growth genes.

This study reviewed the literature on Minoxidil and finasteride for androgenetic alopecia, finding both drugs effective but noting potential side effects, with combined therapy possibly enhancing efficacy and patient adherence while reducing adverse effects.

The April 2014 issue of "Fertility and Sterility" discussed various reproductive health topics, including hormone therapy benefits, sperm and genetic factors in male infertility, and the link between PCOS and diabetes.

This study highlights the growing issue of hair loss around the world and explores the potential of using certain herbs, such as Ficus religiosa and coriander seeds, as natural treatments to promote hair growth and manage hair loss, particularly in India, with minimal side effects.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

Female hair loss patients more likely to have dry eye and gland issues.

This study found that breast cancer treatment with chemotherapy, radiotherapy, and/or hormonal therapy led to a significant increase in blood urea and creatinine levels, indicating nephrotoxicity among non-diabetic, non-cardiac post-menopausal patients with infiltrating ductal carcinoma.

This study reports that NIH PCOS is linked to more severe metabolic issues, including higher obesity and insulin resistance, compared to non-NIH PCOS phenotypes.